Equity-Based Compensation (Schedule Of Stock Appreciation Rights Activity) (Details) - Stock Appreciation Rights (SARs) $ / shares in Units, $ in Thousands	12 Months Ended
	Oct. 01, 2022 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
SARs, Outstanding, Beginning of period | shares	883,423
SARs, Granted | shares	91,788
SARs, Exercised | shares	(108,390)
SARs, Expired | shares	(6,963)
SARs, Forfeited | shares	(1,355)
SARs, Outstanding, End of period | shares	858,503
SARs, Exercisable | shares	666,816
SARs, Weighted Average Exercise Price, Beginning of period | $ / shares	$ 69.37
SARs, Weighted Average Exercise Price, Granted | $ / shares	83.00
SARs, Weighted Average Exercise Price, Exercised | $ / shares	46.72
SARs, Weighted Average Exercise Price, Expired | $ / shares	70.15
SARs, Weighted Average Exercise Price, Forfeited | $ / shares	80.43
SARs, Weighted Average Exercise Price, End of period | $ / shares	73.67
SARs, Weighted Average Exercise Price, Exercisable | $ / shares	$ 71.65
SARs, Weighted Average Remaining Contractual Terms, Outstanding	5 years 1 month 6 days
SARs, Weighted Average Remaining Contractual Terms, Exercisable	4 years 2 months 12 days
SARs, Aggregate Intrinsic Value, Outstanding | $	$ 3,085,580
SARs, Aggregate Intrinsic Value, Exercisable | $	$ 3,085,580